BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Revill PA, Tu T, Netter HJ, Yuen LKW, Locarnini SA, Littlejohn M. The evolution and clinical impact of hepatitis B virus genome diversity. Nat Rev Gastroenterol Hepatol 2020;17:618-34. [DOI: 10.1038/s41575-020-0296-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Roger S, Fontana J, Ducancelle A, Guillou-Guillemette HL, Canivet CM, Lefeuvre C. Acute hepatitis B in pregnancy with surprisingly rapid clearance of serum HBs antigen associated with a favourable outcome. Int J Infect Dis 2022:S1201-9712(22)00134-5. [PMID: 35235825 DOI: 10.1016/j.ijid.2022.02.053] [Reference Citation Analysis]
2 Zhang J, Liu X, Zhou W, Lu S, Wu C, Wu Z, Liu R, Li X, Wu J, Liu Y, Guo S, Jia S, Zhang X, Wang M. Identification of Key Genes Associated With the Process of Hepatitis B Inflammation and Cancer Transformation by Integrated Bioinformatics Analysis. Front Genet 2021;12:654517. [PMID: 34539726 DOI: 10.3389/fgene.2021.654517] [Reference Citation Analysis]
3 Pacin-ruiz B, Cortese MF, Tabernero D, Sopena S, Gregori J, García-garcía S, Casillas R, Najarro A, Aldama U, Palom A, Rando-segura A, Galán A, Vila M, Riveiro-barciela M, Quer J, González-aseguinolaza G, Buti M, Rodríguez-frías F. Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability. Viruses 2022;14:215. [DOI: 10.3390/v14020215] [Reference Citation Analysis]
4 Jiang S, Wang X, Chen K, Yang P. Establishment of an inducible cell line for Hepatitis B virus genotype C2 and its pharmacological responses to interferons. Pharmacol Res 2022;:106142. [PMID: 35218895 DOI: 10.1016/j.phrs.2022.106142] [Reference Citation Analysis]
5 Zhang M, Zhang Z, Imamura M, Osawa M, Teraoka Y, Piotrowski J, Ishida Y, Sozzi V, Revill PA, Saito T, Chayama K, Liang TJ. Infection courses, virological features and IFN-α responses of HBV genotypes in cell culture and animal models. J Hepatol 2021:S0168-8278(21)01960-7. [PMID: 34363922 DOI: 10.1016/j.jhep.2021.07.030] [Reference Citation Analysis]
6 Combet C, Bhardwaj N, Hedskog C, Podlaha O, Gaggar A, Murray KF, Mo H, Svarovskaia E, Zoulim F. Hepatitis B virus genome diversity in adolescents: Tenofovir disoproxil fumarate treatment effect and HBeAg serocon version. J Viral Hepat 2021;28:1160-8. [PMID: 34002910 DOI: 10.1111/jvh.13547] [Reference Citation Analysis]
7 Shi Y, Qian H, Rao P, Mu D, Liu Y, Liu G, Lin Z. Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases. Acta Pharmaceutica Sinica B 2022;12:1126-47. [DOI: 10.1016/j.apsb.2021.09.025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bousali M, Papatheodoridis G, Paraskevis D, Karamitros T. Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma. Microorganisms 2021;9:1787. [PMID: 34442866 DOI: 10.3390/microorganisms9081787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Araujo NM, Osiowy C. Hepatitis B Virus Genotype G: The Odd Cousin of the Family. Front Microbiol 2022;13:872766. [DOI: 10.3389/fmicb.2022.872766] [Reference Citation Analysis]
10 Campos-Valdez M, Monroy-Ramírez HC, Armendáriz-Borunda J, Sánchez-Orozco LV. Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability. Viruses 2021;13:1167. [PMID: 34207116 DOI: 10.3390/v13061167] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jeanes EC, Wegg ML, Mitchell JA, Priestnall SL, Fleming L, Dawson C. Comparison of the prevalence of Domestic Cat Hepadnavirus in a population of cats with uveitis and in a healthy blood donor cat population in the United Kingdom. Vet Ophthalmol 2021. [PMID: 34806802 DOI: 10.1111/vop.12956] [Reference Citation Analysis]
12 Velkov S, Protzer U, Michler T. Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data. Viruses 2020;12:E1344. [PMID: 33238650 DOI: 10.3390/v12111344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Garcia-Garcia S, Cortese MF, Tabernero D, Gregori J, Vila M, Pacín B, Quer J, Casillas R, Castillo-Ribelles L, Ferrer-Costa R, Rando-Segura A, Trejo-Zahínos J, Pumarola T, Casis E, Esteban R, Riveiro-Barciela M, Buti M, Rodríguez-Frías F. Cross-sectional evaluation of circulating hepatitis B virus RNA and DNA: Different quasispecies? World J Gastroenterol 2021; 27(41): 7144-7158 [PMID: 34887634 DOI: 10.3748/wjg.v27.i41.7144] [Reference Citation Analysis]
14 Tu T, Zehnder B, Qu B, Urban S. D e novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA. JHEP Rep. 2021;3:100195. [PMID: 33385130 DOI: 10.1016/j.jhepr.2020.100195] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
15 Niklasch M, Zimmermann P, Nassal M. The Hepatitis B Virus Nucleocapsid-Dynamic Compartment for Infectious Virus Production and New Antiviral Target. Biomedicines 2021;9:1577. [PMID: 34829806 DOI: 10.3390/biomedicines9111577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hernández S, Álvarez-Astudillo F, Garrido D, Prieto C, Loyola A, Villanueva RA. Canonical and Divergent N-Terminal HBx Isoform Proteins Unveiled: Characteristics and Roles during HBV Replication. Biomedicines 2021;9:1701. [PMID: 34829930 DOI: 10.3390/biomedicines9111701] [Reference Citation Analysis]
17 Kim J, Kwon H, Kalsoom F, Sajjad MA, Lee HW, Lim JH, Jung J, Chwae Y, Park S, Shin H, Kim K. Ca2+/Calmodulin-Dependent Protein Kinase II Inhibits Hepatitis B Virus Replication from cccDNA via AMPK Activation and AKT/mTOR Suppression. Microorganisms 2022;10:498. [DOI: 10.3390/microorganisms10030498] [Reference Citation Analysis]
18 Chen X, Zhang M, Li N, Pu R, Wu T, Ding Y, Cai P, Zhang H, Zhao J, Yin J, Cao G. Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma. Aging (Albany NY) 2021;13:22256-75. [PMID: 34534105 DOI: 10.18632/aging.203531] [Reference Citation Analysis]
19 Glebe D, Lehmann F, Goldmann N, Giese A, Hida Y, Gerlich WH, Ziebuhr J, Slanina H, Schüttler CG. [Ten years of the National Reference Center for hepatitis B viruses and hepatitis D viruses in Giessen, Germany: activities and experiences]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2022. [PMID: 35015105 DOI: 10.1007/s00103-021-03479-7] [Reference Citation Analysis]
20 Yang J, Li Y, Ye J, Wang J, Lu H, Yao X. Characterization of the TCR β Chain Repertoire in Peripheral Blood from Hepatitis B Vaccine Responders and Non-Responders. JIR 2022;Volume 15:939-51. [DOI: 10.2147/jir.s347702] [Reference Citation Analysis]
21 Kato Y, Tabata H, Sato K, Nakamura M, Saito I, Nakanishi T. Adenovirus Vectors Expressing Eight Multiplex Guide RNAs of CRISPR/Cas9 Efficiently Disrupted Diverse Hepatitis B Virus Gene Derived from Heterogeneous Patient. Int J Mol Sci 2021;22:10570. [PMID: 34638909 DOI: 10.3390/ijms221910570] [Reference Citation Analysis]
22 Gionda PO, Gomes-Gouvea M, Malta FM, Sebe P, Salles APM, Francisco RDS, José-Abrego A, Roman S, Panduro A, Pinho JRR. Analysis of the complete genome of HBV genotypes F and H found in Brazil and Mexico using the next generation sequencing method. Ann Hepatol 2021;:100569. [PMID: 34757035 DOI: 10.1016/j.aohep.2021.100569] [Reference Citation Analysis]
23 Araujo NM, Teles SA, Spitz N. Comprehensive Analysis of Clinically Significant Hepatitis B Virus Mutations in Relation to Genotype, Subgenotype and Geographic Region. Front Microbiol 2020;11:616023. [PMID: 33381105 DOI: 10.3389/fmicb.2020.616023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Goh ZY, Ren EC, Ko HL. Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B. World J Gastroenterol 2021; 27(14): 1369-1391 [PMID: 33911462 DOI: 10.3748/wjg.v27.i14.1369] [Reference Citation Analysis]
25 Dionne-Odom J, Cozzi GD, Franco RA, Njei B, Tita ATN. Treatment and prevention of viral hepatitis in pregnancy. Am J Obstet Gynecol 2021:S0002-9378(21)00998-4. [PMID: 34516961 DOI: 10.1016/j.ajog.2021.09.002] [Reference Citation Analysis]
26 Pollicino T, Caminiti G. HBV-Integration Studies in the Clinic: Role in the Natural History of Infection. Viruses 2021;13:368. [PMID: 33652619 DOI: 10.3390/v13030368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Castaneda D, Gonzalez AJ, Alomari M, Tandon K, Zervos XB. From hepatitis A to E: A critical review of viral hepatitis. World J Gastroenterol 2021; 27(16): 1691-1715 [PMID: 33967551 DOI: 10.3748/wjg.v27.i16.1691] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
28 Liu Y, Veeraraghavan V, Pinkerton M, Fu J, Douglas MW, George J, Tu T. Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence. Front Microbiol 2021;12:665201. [PMID: 34194408 DOI: 10.3389/fmicb.2021.665201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lin J, Li J, Xie P, Han Y, Yu D, Chen J, Zhang X. Hepatitis B virus middle surface antigen loss promotes clinical variant persistence in mouse models. Virulence 2021;12:2868-82. [PMID: 34738866 DOI: 10.1080/21505594.2021.1999130] [Reference Citation Analysis]
30 Liu T, Liu A, Liu Y, Cen S, Zhang Q. In vitro investigation of HBV clinical isolates from Chinese patients reveals that genotype C isolates possess higher infectivity than genotype B isolates. Virologica Sinica 2022. [DOI: 10.1016/j.virs.2022.03.008] [Reference Citation Analysis]
31 Li J, Yu M, Zong R, Fan C, Ren F, Wu W, Li C. Deacetylation of Notch1 by SIRT1 contributes to HBsAg- and HBeAg-mediated M2 macrophage polarization. Am J Physiol Gastrointest Liver Physiol 2022. [PMID: 35234049 DOI: 10.1152/ajpgi.00338.2021] [Reference Citation Analysis]
32 Locarnini SA, Littlejohn M, Yuen LKW. Origins and Evolution of the Primate Hepatitis B Virus. Front Microbiol 2021;12:653684. [PMID: 34108947 DOI: 10.3389/fmicb.2021.653684] [Reference Citation Analysis]
33 Jo WK, Alfonso-Toledo JA, Salas-Rojas M, Almazan-Marin C, Galvez-Romero G, García-Baltazar A, Obregón-Morales C, Rendón-Franco E, Kühne A, Carvalho-Urbieta V, Rasche A, Brünink S, Glebe D, Aguilar-Setién Á, Drexler JF. Natural co-infection of divergent hepatitis B and C virus homologues in carnivores. Transbound Emerg Dis 2021. [PMID: 34606685 DOI: 10.1111/tbed.14340] [Reference Citation Analysis]
34 Panasiuk YV, Vlasenko NV, Churilova NS, Klushkina VV, Dubodelov DV, Kudryavtseva EN, Korabelnikova MI, Rodionova ZS, Semenenko TA, Kuzin SN, Akimkin VG. [Modern views on the role of X gene of the hepatitis B virus (Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus) in the pathogenesis of the infection it causes]. Vopr Virusol 2022;67:7-17. [PMID: 35293184 DOI: 10.36233/0507-4088-84] [Reference Citation Analysis]
35 Boudewijns R, Ma J, Neyts J, Dallmeier K. A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice. JHEP Rep 2021;3:100295. [PMID: 34159304 DOI: 10.1016/j.jhepr.2021.100295] [Reference Citation Analysis]
36 Zhang F, Li Y, Gan L, Tong X, Qi D, Wang Q, Ye X. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA. FASEB J 2021;35:e21529. [PMID: 33813778 DOI: 10.1096/fj.202002374R] [Reference Citation Analysis]
37 Lim CS, Sozzi V, Littlejohn M, Yuen LKW, Warner N, Betz-Stablein B, Luciani F, Revill PA, Brown CM. Quantitative analysis of the splice variants expressed by the major hepatitis B virus genotypes. Microb Genom 2021;7. [PMID: 33439114 DOI: 10.1099/mgen.0.000492] [Reference Citation Analysis]
38 Chen R, Du J, Zhu H, Ling Q. The role of cGAS-STING signalling in liver diseases. JHEP Rep 2021;3:100324. [PMID: 34381984 DOI: 10.1016/j.jhepr.2021.100324] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Sadeghian I, Heidari R, Sadeghian S, Raee MJ, Negahdaripour M. Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines. Eur J Pharm Sci 2021;169:106094. [PMID: 34896590 DOI: 10.1016/j.ejps.2021.106094] [Reference Citation Analysis]